Business

Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First Subject

Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First Subject

articleBeijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class AApril 14, 20253/news/announcement-on-initiating-phase-iii-clinical-trial-of-9-valent-hpv-vaccine-for-men-and-completing-the-enrollment-of-first-subject
Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First Subject

About this update from Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A

Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First SubjectThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A